BURLINGTON Mass. Nov. 15 2011 PRNewswire Coronado Biosciences Inc. a company focused on novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer today announced financial results for the third quarter ended September 30 2011...
↧